Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform
Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform
About this item
Full title
Author / Creator
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
BackgroundOncolytic adenoviruses (OAds) demonstrated great potential for the treatment of cancer in many pre-clinical studies. The pre-existing immunity and their immunodominance, however, still limit the success of oncolytic virotherapy in cancer patients. Thus, a transition from oncolytic agents to oncolytic vaccines seems to be necessary, since...
Alternative Titles
Full title
Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4649305
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4649305
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1186/2051-1426-3-S2-P333
